Navigation Links
Cardiac events better treated with intense cholesterol-lowering regime

Investigators from the Weatherhead P.E.T. Center for Preventing and Reversing Atherosclerosis in Houston, Texas, United States, have suggested in a new study that intense lifestyle changes plus pharmacologic lipid treatment reduces myocardial perfusion abnormalities and cardiac events to a greater extent than usual-care cholesterol lowering drugs. They studied 409 patients with coronary artery// disease by performing myocardial perfusion imaging at baseline and after 2.6 years with software-based quantitative measurement of perfusion defects. Cardiac events were monitored during an additional five-year follow-up period.

The patients who participated in the study were divided into three categories depending on the type of treatment that was given to them. The "poor" treatment group included patients who were neither dieting nor taking lipid-lowering drugs and patients who were smoking. The "moderate" treatment group was put on the American Heart Association diet with lipid lowering drugs or a strict diet with less than 10% of calories from fat. And, the "maximal" treatment group consisted of patients who were put on strict low-fat diet, regular exercise and lipid active drugs.

Researchers, during the five-year follow-up period, found out that cardiac events occurred in 20.3% of the patients in the moderate treatment group and 30.6% of patients in the poor treatment group. In contrast, cardiac events occurred in only 6.6% of the patients in the maximal treatment group. Also, the size and severity of perfusion abnormalities decreased in the maximal treatment group but increased in both the poor and moderate treatment groups. Changes in myocardial perfusion paralleled the intensity of treatment and predicted cardiac events.


'"/>




Page: 1

Related medicine news :

1. Cardiac diseases develop early
2. Heart problems detected better with a Cardiac MRI
3. Sudden Cardiac Death due to inherited Heart Disease
4. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
5. Stem Cells From Bone Marrow Found To Improve Cardiac Functioning After A Heart Attack
6. Cardiac – Rehabilitation Programs Beneficial for Heart Patient
7. Cardiac Valve Disease Linked To Genes
8. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
9. Prevent Cardiac Problems And Laugh Your Way To Good Health
10. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
11. Glucose may support in Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... Lake City, Colo. (PRWEB) , ... April 21, 2017 , ... ... launch of the Flex House, the next project in the company’s esteemed VISION House ... to help homeowners use exactly the amount of resources they need to live affordably ...
(Date:4/21/2017)... Kong (PRWEB) , ... April 21, 2017 , ... The ... (U3DP), the first 3D printing facility among higher education institutions in Hong Kong to ... printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... 2017 , ... Alive for Wellness is a group of clinical ... struggles. The Alive team uses advanced behavioral sciences treatment modalities to accomplish their ... mental health struggle is based on 10 modalities of treatment that include: ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... 21, 2017 , ... BrightStar Care Salt Lake City, a home care agency ... (APCUT) and has appointed Rex Wheeler as its new Director of Business Development. “This ... and our ability to provide quality care to the community,” said Tammara Brown, owner ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
Breaking Medicine Technology: